• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-192 和 miR-194 通过 EMT 对常染色体显性多囊肾病囊肿增大的影响。

Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.

机构信息

Department of Biological Sciences, Sookmyung Women's University, Seoul, South Korea.

Research Institute of Women's Health, Sookmyung Women's University, Seoul, South Korea.

出版信息

FASEB J. 2019 Feb;33(2):2870-2884. doi: 10.1096/fj.201800563RR. Epub 2018 Oct 17.

DOI:10.1096/fj.201800563RR
PMID:30332302
Abstract

Altered miRNA (miR) expression occurs in various diseases. However, the therapeutic effect of miRNAs in autosomal dominant polycystic kidney disease (ADPKD) is unclear. Genome-wide analyses of miRNA expression and DNA methylation status were conducted to identify crucial miRNAs in end-stage ADPKD. miR-192 and -194 levels were down-regulated with hypermethylation at these loci, mainly in the intermediate and late stages, not in the early stage, of cystogenesis, suggesting their potential impact on cyst expansion. Cyst expansion has been strongly associated with endothelial-mesenchymal transition (EMT). Zinc finger E-box-binding homeobox-2 and cadherin-2, which are involved in EMT, were directly regulated by miR-192 and -194. The therapeutic effect of miR-192 and -194 in vivo and in vitro were assessed. Restoring these miRs by injection of precursors influenced the reduced size of cysts in Pkd1 conditional knockout mice. miR-192 and -194 may act as potential therapeutic targets to control the expansion and progression of cysts in patients with ADPKD.-Kim, D. Y., Woo, Y. M., Lee, S., Oh, S., Shin, Y., Shin, J.-O., Park, E. Y., Ko, J. Y., Lee, E. J., Bok, J., Yoo, K. H., Park, J. H. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.

摘要

miRNA(miR)表达的改变发生在各种疾病中。然而,miRNAs 在常染色体显性多囊肾病(ADPKD)中的治疗效果尚不清楚。对 miRNA 表达和 DNA 甲基化状态进行全基因组分析,以确定终末期 ADPKD 中的关键 miRNA。miR-192 和 -194 的水平下调与这些基因座的高甲基化有关,主要发生在囊泡形成的中晚期,而不是早期,表明它们对囊泡扩张有潜在影响。囊泡扩张与内皮-间充质转化(EMT)密切相关。锌指 E 盒结合同源盒 2 和钙黏蛋白-2,参与 EMT,直接受 miR-192 和 -194 调控。在体内和体外评估了 miR-192 和 -194 的治疗效果。通过注射前体恢复这些 miR 会影响 Pkd1 条件性敲除小鼠中囊肿体积的缩小。miR-192 和 -194 可能作为潜在的治疗靶点,以控制 ADPKD 患者囊肿的扩张和进展。-Kim, D. Y., Woo, Y. M., Lee, S., Oh, S., Shin, Y., Shin, J.-O., Park, E. Y., Ko, J. Y., Lee, E. J., Bok, J., Yoo, K. H., Park, J. H. 通过 EMT 在常染色体显性多囊肾病中影响囊肿增大的 miR-192 和 miR-194。

相似文献

1
Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.miR-192 和 miR-194 通过 EMT 对常染色体显性多囊肾病囊肿增大的影响。
FASEB J. 2019 Feb;33(2):2870-2884. doi: 10.1096/fj.201800563RR. Epub 2018 Oct 17.
2
Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis.KLF12 在囊泡生成中的 miRNA-20b 和 miRNA-106a 调控。
FASEB J. 2018 Jul;32(7):3574-3582. doi: 10.1096/fj.201700923R. Epub 2018 Feb 16.
3
ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.ZEB2 通过 SIRT1 和 DNMTs 的表观遗传调控稳定抑制 RAB25 的表达,从而在上皮-间充质转化过程中。
Epigenetics Chromatin. 2018 Nov 16;11(1):70. doi: 10.1186/s13072-018-0239-4.
4
Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.平行微阵列分析鉴定出 ErbB4 是 ADPKD 囊肿生长的决定因素和疾病进展的预后生物标志物。
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F577-F588. doi: 10.1152/ajprenal.00607.2016. Epub 2017 Jan 11.
5
Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.抗 microRNA 筛选揭示 miR-17 家族在 miR-17~92 簇中是肾脏囊肿生长的主要驱动因素。
Sci Rep. 2019 Feb 13;9(1):1920. doi: 10.1038/s41598-019-38566-y.
6
Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models.多囊肾病小鼠模型中与囊肿发生相关的 miRNA 及其靶基因的分析。
Sci Rep. 2017 Oct 26;7(1):14151. doi: 10.1038/s41598-017-14083-8.
7
Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).甘替斯培抑制常染色体显性多囊肾病(ADPKD)中的纤毛和囊泡生成。
FASEB J. 2018 May;32(5):2735-2746. doi: 10.1096/fj.201700909R. Epub 2018 Jan 10.
8
Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.对 ADPKD 的全基因组甲基化谱进行分析,确定了与肾脏囊肿发育相关的受表观遗传调控的基因。
Hum Genet. 2014 Mar;133(3):281-97. doi: 10.1007/s00439-013-1378-0. Epub 2013 Oct 16.
9
Therapeutic microRNAs in polycystic kidney disease.多囊肾病中的治疗性微小RNA
Curr Opin Nephrol Hypertens. 2017 Jul;26(4):282-289. doi: 10.1097/MNH.0000000000000333.
10
miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.miR-17~92 miRNA 簇促进多囊肾病中的肾囊肿生长。
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10765-70. doi: 10.1073/pnas.1301693110. Epub 2013 Jun 12.

引用本文的文献

1
A miRNA-Based Approach in Autosomal Dominant Polycystic Kidney Disease: Challenges and Insights from Adult to Pediatric Evidence.基于微小RNA的常染色体显性多囊肾病治疗方法:从成人到儿童证据的挑战与见解
Mol Diagn Ther. 2025 Mar;29(2):183-193. doi: 10.1007/s40291-024-00761-7. Epub 2025 Jan 17.
2
miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor.微小RNA-192通过靶向rictor抑制肝星状细胞的激活。
Open Med (Wars). 2023 Dec 26;18(1):20230879. doi: 10.1515/med-2023-0879. eCollection 2023.
3
miR-23b-3p Ameliorates LPS-Induced Pulmonary Fibrosis by Inhibiting EndMT via DPP4 Inhibition.
微小RNA-23b-3p通过抑制二肽基肽酶4以抑制内皮-间充质转化来改善脂多糖诱导的肺纤维化
Mol Biotechnol. 2025 Jan;67(1):175-186. doi: 10.1007/s12033-023-00992-9. Epub 2023 Dec 27.
4
Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease.非编码RNA作为多囊肾病的潜在生物标志物和治疗靶点
Front Physiol. 2022 Sep 20;13:1006427. doi: 10.3389/fphys.2022.1006427. eCollection 2022.
5
MicroRNAs in kidney injury and disease.微小 RNA 与肾脏损伤和疾病
Nat Rev Nephrol. 2022 Oct;18(10):643-662. doi: 10.1038/s41581-022-00608-6. Epub 2022 Aug 16.
6
Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病中的染色质甲基化异常
Front Med (Lausanne). 2022 Jul 5;9:921631. doi: 10.3389/fmed.2022.921631. eCollection 2022.
7
Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment.常染色体显性遗传性多囊肾病:从囊肿发生的病理生理学到治疗的进展。
Int J Mol Sci. 2022 Mar 19;23(6):3317. doi: 10.3390/ijms23063317.
8
A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers.微小RNA在囊性疾病中的调控作用及其作为潜在生物标志物的应用简述
Genes (Basel). 2022 Jan 22;13(2):191. doi: 10.3390/genes13020191.
9
Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease.多囊肾病表观遗传修饰的最新发现。
Int J Mol Sci. 2021 Dec 11;22(24):13327. doi: 10.3390/ijms222413327.
10
Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.常染色体显性多囊肾病上皮细胞中的病理性转录鉴定。
Sci Rep. 2021 Jul 23;11(1):15139. doi: 10.1038/s41598-021-94442-8.